Early National Experience with Laparoscopic Pancreaticoduodenectomy for Ductal Adenocarcinoma: A Comparison of Laparoscopic Pancreaticoduodenectomy and Open Pancreaticoduodenectomy from the National Cancer Data Base
Overview
Gynecology & Obstetrics
Authors
Affiliations
Background: There is considerable debate about the safety and clinical equivalence of laparoscopic pancreaticoduodenectomy (LPD) and open pancreaticoduodenectomy (OPD) for pancreatic ductal adenocarcinoma (PDCA).
Study Design: We queried the National Cancer Data Base to identify patients undergoing LPD and OPD for PDCA between 2010 and 2011. Chi-square and Student's t-tests were used to evaluate differences between the 2 approaches. Multivariable logistic regression modeling was performed to identify patient, tumor, or facility factors associated with perioperative mortality.
Results: Four thousand and thirty-seven (91%) patients underwent OPD. Three hundred and eighty-four (9%) patients underwent LPD. There were no statistical differences between the 2 surgical cohorts with regard to age, race, Charlson score, tumor size, grade, stage, or treatment with neoadjuvant chemoradiotherapy. Laparoscopic pancreaticoduodenectomy demonstrated a shorter length of stay (10 ± 8 days vs 12 ± 9.7 days; p < 0.0001) and lower rates of unplanned readmission (5% vs 9%; p = 0.027) than OPD. In an unadjusted comparison, there was no difference in 30-day mortality between the LPD and OPD cohorts (5.2% vs 3.7%; p = 0.163). Multivariable logistic regression modeling predicting perioperative mortality controlling for age, Charlson score, tumor size, nodal positivity, stage, facility type, and pancreaticoduodenectomy volume identified age (odds ratio [OR] = 1.05; p < 0.0001), positive margins (OR = 1.45; p = 0.030), and LPD (OR = 1.89; p = 0.009) as associated with an increased probability of 30-day mortality; higher hospital volume was associated with a lower risk of 30-day mortality (OR = 0.98; p < 0.0001). In institutions that performed ≥10 LPDs, the 30-day mortality rate of the laparoscopic approach was equal to that for the open approach (0.0% vs 0.7%; p = 1.00).
Conclusions: Laparoscopic pancreaticoduodenectomy is equivalent to OPD in length of stay, margin-positive resection, lymph node count, and readmission rate. There is a higher 30-day mortality rate with LPD, but this appears driven by a surmountable learning curve for the procedure.
Feng J, Zhao Y, Liang H, Jiang K, Dai R World J Gastrointest Surg. 2025; 17(1):100291.
PMID: 39872782 PMC: 11757197. DOI: 10.4240/wjgs.v17.i1.100291.
Joseph N, Varghese C, Lucocq J, McGuinness M, Tingle S, Marchegiani G Ann Surg Open. 2024; 5(4):e507.
PMID: 39711682 PMC: 11661753. DOI: 10.1097/AS9.0000000000000507.
Current landscape of minimally invasive pancreatectomy for neoplasms: A retrospective cohort study.
Ngongoni R, Mlambo B, Shih I, Li Y, Wren S World J Surg. 2024; 49(1):241-252.
PMID: 39578686 PMC: 11711114. DOI: 10.1002/wjs.12408.
Yumoto S, Hayashi H, Mima K, Ogawa D, Itoyama R, Kitano Y Ann Surg Open. 2024; 5(3):e487.
PMID: 39310352 PMC: 11415100. DOI: 10.1097/AS9.0000000000000487.
Tran A, Zheng R, Johnston F, He J, Burns W, Shubert C HPB (Oxford). 2024; 26(10):1280-1290.
PMID: 39033045 PMC: 11446651. DOI: 10.1016/j.hpb.2024.07.403.